Bicisate Dihydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002534
Compound index — B
887 substances begin with B. 5 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Bicisate Dihydrochloride – Bordetella pertussis….
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Bictegravir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; J05AR20; Nucleoside Reverse Transcriptase Inhibitors [MoA]
Earliest US approval2018
Market presence12 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002535
Bictegravir, Emtricitabine And Tenofovir Alafenamide US-DRUG Not yet graded
Earliest US approval2025
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002536
Bicyclo(2.2.1)heptan-2-one, 1,7,7-trimethyl-, (1S,4S)- CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002537
Bidens pilosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002538
Bidens Pilosa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002539
Bifenthrin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002540
Bifidobacterium (BB12) fortified cultured milk (Hodzeko-Amasi) EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Bifidobacterium cultures enhances natural immune function, helps maintain blood cholesterol” | Non-authorised | Art.13(1) | EFSA opinion |
| “Bifidobacterium cultures enhances natural immune function,reduces symptoms of inflammatory bowel conditions” | Non-authorised | Art.13(1) | EFSA opinion |
| “Bifidobacterium cultures enhances natural immune function.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002572
Bifidobacterium adolescentis BA 02 (DSM 17103) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- rebalances the intestinal motility function; -contributes to the rebalancing of intestinal microflora; - supports the maintenance of intestinal homeostasis; -promotes the wellbeing of the intestine; -restores intestinal flora bacteria in the elderly; -optimizes intestinal transit in the elderly.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002542
Bifidobacterium adolescentis EI-15 -ALB 1 (DSM 18351) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- promotes the wellbeing of the intestine;- contributes to restoring intestinal bacterial flora;- contributes to the rebalancing of intestinal microflora;- improves the metabolic activity of intestinal microflora.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002543
Bifidobacterium adolescentis EI-18 -MB 227-BA05 (DSM 18352) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- produces folic acid;- supports the maintenance of intestinal homeostasis;- promotes the wellbeing of the intestine.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002544
Bifidobacterium adolescentis EI-3 -MB 239 (DSM 18350) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- produces folic acid and riboflavin;- supports the maintenance of intestinal homeostasis;- contributes to the rebalancing of intestinal microflora;- promotes the wellbeing of the intestine.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002545
Bifidobacterium animalis EU-NOVEL Not yet graded
Not novel in food
also: Bifidobacterium lactis, Bifidobacterium animalis ssp. lactis
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002546
Bifidobacterium Animalis Lactis BL04 US-DRUG Not yet graded
US: unapproved drug other
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002547
Bifidobacterium animalis Lafti B94 (CBS118.529) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “probiotic enhances levels of beneficial microflora balances your intestinal microflora beneficially affects the intestinal flora supports a balanced beneficial gastro-intestinal microflora” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002548
Bifidobacterium animalis ssp animalis THT 010401 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002549
Bifidobacterium animalis ssp. lactis BB-12 ® EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic -support your natural defences; -strenghten the natural defense.” | Non-authorised | Art.13(1) | EFSA opinion |
| “-Probiotic. -Contributes to a healthy level of natural good bacteria in your body, which can aid digestion. -Supports a healthy digstive system. -Beneficially affects the intestinal flora.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002550
Bifidobacterium animalis ssp. lactis BB-12® and Lactobacillus acidophilus LA-5® EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic -improves the microflora in elderly; -beneficially affects the microflora; -helps to keep your digestive system in balance; -helps maintain a healthy digestive system; -helps maintain a healthy gut flora.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- probiotic -helps to support your natural defences; -helps to strenghten the natural defense; -helps to stimulate the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002552
Bifidobacterium animalis ssp. lactis BB-12® and Lactobacillus paracasei ssp. paracasei CRL-431® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic '-helps against slow transit; -improves the gastrointestinal flora.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002551
Bifidobacterium animalis ssp. lactis BB-12®, Lactobacillus acidophilus LA-5®, Lactbacillus bulgaricus LBY-27 and Streptococcus thermophilus STY-31 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “'- probiotic '-helps maintain a healthy gut flora -helps maintain intestinal comfort -helps support the gut microflora -helps to reduce uncomfortable intestinal disturbances” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002553
Bifidobacterium animalis ssp. lactis BB-12®, Lactobacillus acidophilus LA-5®, Lactbacillus bulgaricus LBY-27® and Streptococcus thermophilus STY-31® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-intestinal comfort - helps to support digestive flora - helps to reduce uncomfortable intestinal disturbances” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002554
Bifidobacterium animalis ssp. lactis BB-12®, Lactobacillus acidophilus LA-5®, Lactobacillus delbrueki ssp. bulgaricus LBY-27 and Streptococcus thermophilus STY-31 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic -enhances/supports your bodys natural defence.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002555
Bifidobacterium animalis ssp. lactis Bf-6/Bif-6/CB111 EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “supports the natural beneficial gut flora ; contributes to healthy intestinal microflora ; contributes to healthy digestive system” | Non-authorised | Art.13(1) | EFSA opinion |
| “supports the natural beneficial gut flora ; contributes to healthy intestinal microflora ; contributes to healthy digestive system” | Non-authorised | Art.13(1) | EFSA opinion |
| “supports the natural beneficial gut flora ; contributes to healthy intestinal microflora ; contributes to healthy digestive system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002556
Bifidobacterium animalis ssp. lactis Bf-6/Bif-6/CB111 and Lactobacillus johnsonii La-1/ACD-1/CLbA22 (A/B-61) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “support the natural beneficial gut flora ; contribute to healthy intestinal microflora ; contribute to healthy digestive system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002557
Bifidobacterium animalis ssp. lactisTHT 010801 EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to improve intestinal transit * Helps to reduce natural digestion * Helps to regulate intestinal flora * Promotes intestinal comfort” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002558
Bifidobacterium animalis subsp. animalis CA-NHP Not yet graded
CA licensed ingredient
Market presence59 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002559
Bifidobacterium animalis subsp. lactis CA-NHP Not yet graded
CA licensed ingredient
Market presence2,793 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002560
Bifidobacterium animalis subsp. lactis (Bi‐07) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Bifidobacterium animalis subsp. lactis Bi-07 contributes to the improvement of lactose digestion in individuals who have difficulty digesting lactose” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005534
Bifidobacterium bifidum CNCM I-3426 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Bifidobacterium bifidum CNCM I-3426 increases the proportion of healthy days by maintaining normal immune function in healthy adults during everyday life events such as moderate stress.” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005533
Bifidobacterium bifidum CNCM I-373 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “'- probiotic -helps maintain a healthy gut flora.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002562
Bifidobacterium bifidum I-3426 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “' probiotic -helps to strenghten your body's natural defences; -helps to strenghten the natural defenses; '-helps to stimulate the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
| “- probiotic '-helps maintain a healthy gut flora;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002563
Bifidobacterium bifidum THT 010101 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002564
Bifidobacterium breve BL 03 (DSM 16603) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- promuove la funzione motoria intestinale; - contribuisce al riequilibrio della microflora intestinale; - favorisce il mantenimento dell'omeostasi intestinale; - ottimizza il transito intestinale nell'anziano.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002566
Bifidobacterium breve BR 03 (DSM 16604) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- riequilibria la funzione motoria intestinale; contribuisce al riequilibrio della microflora intestinale; ; - migliora l'attività metabolica della microflora ; intestinale; ; - ottimizza il transito intestinale nell'anziano.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002567
Bifidobacterium breve BR 03 (DSM 16604) +Lactobacillus plantarum LP 01 (LMG P-21021) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- supports the maintenance of intestinal homeostasis;- supports the maintenance of intestinal homeostasis in children;- contributes to reducing gastro-intestinal discomfort;- contributes to reducing gastro-intestinal discomfort in children;- reduces f” | Non-authorised | Art.13(1) | EFSA opinion |
| “- favorisce il mantenimento dell'omeostasi intestinale; - contribuisce a ridurre il discomfort gastro-intestinale; - riduce la flatulenza ed il gonfiore addominale; - riequilibria la funzione motoria intestinale; - ottimizza il transito intestinale; - riequilibria la composizione della microflora dopo trattamento con antibiotici.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002568
Bifidobacterium breve I-3425 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic '-helps balance the intestinal flora; -helps maintain digestive health.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- probiotic -helps body's natural defences; '-helps to strenghten the natural defenses; '-helps to stimulate the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002569
Bifidobacterium breve THT 010601 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002570
Bifidobacterium Brevis CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002571
Bifidobacterium infantis Bi1 (LMG P-17502), Bifidobacterium breve Bbr8 (LMG P-17501) and Bifidobacterium longum Bl10 (LMG P-17500) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “*balances your intestinal microflora * promotes and maintains intestinal health * promotes and maintains intestinal function * supports healthy gastrointestinal flora” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002573
Bifidobacterium infantis I-3424 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “'- probiotic -helps maintain digestive health.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- probiotic -helps body's natural defences; '-helps to strenghten the natural defenses; '-helps to stimulate the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002574
Bifidobacterium infantis UCC35624 EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Balances your healthy intestinal flora by enhancing levels of beneficial or healthy bacteria Promotes a well balanced gut flora by replenishing healthy, beneficial bacteria” | Non-authorised | Art.13(1) | EFSA opinion |
| “Enhances the body's natural immune response. Helps positively influence a healthy immune system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Provides friendly bacteria that play an important role in basic digestion, proper metabolism and overall well-being. Will boost the level of natural good bacteria in your body, which can aid digestion and general well-being” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002575
Bifidobacterium lactis CA-NHP Not yet graded
CA licensed ingredient
Market presence79 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002576
Bifidobacterium lactis B420 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Probiotics; '-helps to improve the level of natural good bacteria in your body; -maintains the balance of healthy microflora; -beneficially affects the intestinal flora;” | Non-authorised | Art.13(1) | EFSA opinion |
| “Probiotics; '-helps to improve the level of natural good bacteria in your body; -maintains the balance of healthy microflora; -beneficially affects the intestinal flora;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002577
Bifidobacterium lactis Bi-07 (ATCC SD5220) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- probiotic - helps body's natural defences; '- helps to strenghten the natural defenses;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002578
Bifidobacterium lactis BS 01 (LMG P-21384) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- riequilibria la funzione motoria intestinale; - riequilibria la composizione della microflora dopo trattamento con antibiotici; - migliora l'attività metabolica della microflora intestinale; - promuove il benessere dell'intestino.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002579
Bifidobacterium lactis BS 01 (LMG P-21384)+Lactobacillus rhamnosus LR 04 (DSM 16605)+ Lactobacillus plantarum LP 02(LMG P-21020)+Lactoferrin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- supports the natural defences of the organism;- strengthens natural defences;- contributes to the maintenance of intestinal wellbeing;- promotes the maintenance of intestinal homeostasis;- restores intestinal bacterial flora.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002581
Bifidobacterium lactis BS 01 (LMG P-21384)+Lactobacillus rhamnosus LR 04 (DSM 16605)+Lactobacillus plantarum LP 02(LMG P-21020) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- supporta le naturali difese dell'organismo; - rinforza le difese naturali; - contribuisce al mantenimento del benessere intestinale; - favorisce il mantenimento dell'omeostasi intestinale; - reintegra la flora batterica intestinale.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002580
Bifidobacterium longum bv infantis THT 010201 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005535
Bifidobacterium longum I-3470 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “'- probiotic -helps balance the intestinal flora; -helps maintain digestive health.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- probiotic -helps body's natural defences; '-helps to strenghten the natural defenses; '-helps to stimulate the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005536
Bifidobacterium longum subsp. infantis CA-NHP Not yet graded
CA licensed ingredient
Market presence1,768 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002583
Bifidobacterium longum subsp. infantis 35624 CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002584
Bifidobacterium longum subsp. longum CA-NHP Not yet graded
CA licensed ingredient
Market presence3,328 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002585
Bifidobacterium longum subsp. suis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002586
Bifidobacterium longum THT 010301 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005537
Bifidobacterium longum W11(LMG P-21586) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- contributes to the rebalancing of intestinal microflora;- rebalances the intestinal motility function;- supports the maintenance of intestinal homeostasis;- promotes the wellbeing of the intestine;- contributes to reducing gastro-intestinal discomfort;” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005538
Bifidobacterium pseudocatenulatum EI-20 -MB 116 (DSM 18353) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- produces folic acid and riboflavin;- supports the maintenance of intestinal homeostasis;- contributes to the rebalancing of intestinal microflora;- promotes the wellbeing of the intestine.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002587
Bifidobacterium pseudolongum EU-NOVEL Not yet graded
Not novel in food
also: Bifidobacterium pseudolongum subsp. globosum
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002588
Bifidobacterium pseudolongum ssp pseudolongum THT 010501 EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “* Helps to strengthen natural defences * Stimulates immune system * Strengthens resistance of organism” | Non-authorised | Art.13(1) | EFSA opinion |
| “* Maintains/restores the balance of intestinal flora * Promotes intestinal comfort * Strengthens resistance of organism * Improves digestive health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002589
Bifidobacterium thermophilum EU-NOVEL Not yet graded
Not novel in food
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002590
Bifidophilus infantis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002591
bifikafusp alfa EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01XY
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002592
Bignonia lactiflora EU-NOVEL Not yet graded
Bignonia rigescens EU-NOVEL Not yet graded
Bignonia sempervirens CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002595
Bilastine US-DRUG Not yet graded
US: bulk ingredient
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002596
Bilberry US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-Inflammatory Agents; Antimalarial [EPC]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002597
Bilberry and anthocyanins from blackcurrant EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “The anthocyanins from bilberry and mountain blackcurrant are good for the eyes (improve adaptation to the dark and relieve eye tiredness caused by computer terminal work).” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002598
Bile CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002599
Bile extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002600
Bile salts CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002601
Bilirubin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002602
Bimatoprost EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedProstaglandin Analog [EPC]; Prostaglandins [CS]; S01ED51; S01EE03
Earliest US approval2001
Market presence53 US product listings · 25 FDA applications · 3 EU medicines
Etalyn identifierETA-C-002603
Bimatoprost Grenod US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002604
Bimekizumab-Bkzx US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002606
Bimuno (BGOS) Prebiotic, a ß-galacto-oligosaccharide mixture EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Regular consumption of Bimuno (BGOS) Prebiotic helps to protect against the bad bacteria than can cause the travellers diarrhoea” | Non-authorised | Art.14(1)(a) | EFSA opinion |
| “Helps maintain a healthy gastro-intestinal (GI) function” | Non-authorised | Art.13(5) | EFSA opinion |
| “Supports your natural defences” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002609
Bimuno® (Bimuno® GOS) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Regular daily consumption of 1.37 g galacto-oligosaccharides from Bimuno® may reduce intestinal discomfort” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002607
Bimuno® GOS EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce abdominal discomfort.” | Non-authorised | Art.13(5) | EFSA opinion |
| “Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce adbominal discomfort” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002608
Binetrakin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002610
Binimetinib EU-MEDUS-DRUG Not yet graded
BIO-11006 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002612
Bioaktive Oligosaccharide, wie z. B. glykosylierte Phenylethanoide EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “[In german: ] Bioaktive Oligosaccharide gehören zu den stärksten Radikalfängern Antioxidantien aus der Natur. Bioaktive Oligosaccharide fangen freie Radikale ab. Clarification provided Bioactive oligosaccharides are among the strongest natural radical scavenger/ natural andioxidatiants so that they can trap radicals effectively” | Non-authorised | Art.13(1) | EFSA opinion |
| “[In german: ] Bioaktive Oligosaccharide zur natürlichen / aktiven Unterstützung / Optimierung der Muskelkraft. Clarification provided Bioactive oligosaccharides optimise mucular strength.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002613
Bioalfa plus e biogenina, associati a sostanze antiossidanti (quercitina, zinco e rame) [1] EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contrastano gli effetti nocivi dei radicali liberi sul bulbo del capello e controbuiscono a ridargli vitalità. Clarification provided work against the negative effect of free radicals on the hair bulb revitalizing the hair” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002614
Bioflavonoids CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 3 refusedCA licensed ingredient
Market presence143 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to maintain healthy venous circulation” | Non-authorised | Art.13(1) | EFSA opinion |
| “Interviene positivamente sul trofismo microcircolatorio - per favorire i processi di protezione dei piccoli vasi venosi. concorre alla protezione dall'azione nociva dei radicali liberi sull'organismo e da quella dei raggi ultravioletti sulla pelle. Clarification provided Antioxidant effects to enhance the microcirculation resistance and protection of venous vessels fron the attack of free radicals.” | Non-authorised | Art.13(1) | EFSA opinion |
| ““Bioflavonoids support a healthy immune system”.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-002615
Bioflavonoids from citrus EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to maintain healthy venous circulation.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002616
Bioperin CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002617
Biota orientalis CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002618
Biotin CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 7 authorised / 5 refusedCA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Earliest US approval1947
Market presence115 US product listings · 15 FDA applications · 8,733 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Biotin contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to normal macronutrient metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to normal psychological function” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to the maintenance of normal hair” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to the maintenance of normal mucous membranes” | Authorised | Art.13(1) | EFSA opinion |
| “Biotin contributes to the maintenance of normal skin” | Authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary to maintain energy and general vitality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Ensures normal functioning of the body's organ tissues and systems, particularly in old age - Stimulates physical work capacities - Recommended in case of intense fatigue and during recovery” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Necessary for healthy teeth, bones, hair, skin and nails” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-002619
Biotinoyl Tripeptide-1 US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002620
Biperiden Lactate US-DRUG Not yet graded
Earliest US approval1959
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002621
Birch CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002622
Birch Tar Oil Rectified CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002623
Birch Triterpenes US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002624
Bis(2,4-Dichlorobenzoyl) Peroxide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antiseptic [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002626
BIS-Ethylhexyloxyphenol Methoxyphenyl Triazine US-DRUG Not yet graded
US: unapproved drug other
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002627
Bisacodyl US-DRUG Not yet graded
US: bulk ingredient
Class as recordedIncreased Large Intestinal Motility [PE]; Stimulant Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Earliest US approval2004
Market presence138 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002628
Bismuth CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence55 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-002629
Bismuth Hydroxide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002630
Bismuth Oxide US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBismuth [CS]; Bismuth [EPC]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002631
Bismuth Subcarbonate US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002632
Bismuth Subcitrate US-DRUG Not yet graded
US: anda
Class as recordedBismuth [CS]; Bismuth [EPC]; Nitroimidazole Antimicrobial [EPC]; Nitroimidazoles [CS]
Earliest US approval2006
Market presence9 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002633
Bismuth Subgallate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBismuth [CS]; Bismuth [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002634
Bismuth Subnitrate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Bismuth [CS]; Bismuth [EPC]; Blood Coagulation Factor [EPC]
Market presence39 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002635
Bismuth Subsalicylate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBismuth [CS]; Bismuth [EPC]
Earliest US approval1996
Market presence260 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002636
Bismuth Tribromophenate US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002637
Bismuthum metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002638
Bismuthum Oxydatum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002639
Bismuthum subnitricum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002640
Bisoctrizole US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002641
Bisoprolol US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta-Antagonists [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
Earliest US approval1992
Market presence107 US product listings · 30 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002642
Bisphenol A US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002643
Bistorta officinalis CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002644
Bitolterol Mesylate US-DRUG Not yet graded
Earliest US approval1984
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002645
Bitter Almond US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002646
Bitter Evodia Root CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002647
Bitter melon CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002648
Bivalirudin EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: anda
Class as recordedAnti-coagulant [EPC]; B01AE06; Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
Earliest US approval2000
Market presence26 US product listings · 16 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002649
Black Currant EU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 1 refusedUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Androgen Receptor Agonists [MoA]; Androgen [EPC]
Market presence4 US product listings
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Support of venous circulation - Helps to reduce the feeling of tired and heavy legs - Helps to maintain healthy leg-vein functions - Promotes circulatory well-being - Favourable influence on the blood circulation - For legs relief and to favour comfort” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-002651
Black Currant juice EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Blackcurrent juice helps to : - protect cells against oxidative damages - strengthen the immune system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Blackcurrent juice helps to: - improve the urinary tract immune function. - support the normal functionning of the urinary tract.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002652
Black Mustard Seed US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence33 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002653
Black Olive US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002654
Black rice (Oriza sativa indica), consumed as such, or the bran (pigment fraction) of black rice used as a food ingredient in foods, in particular yoghurts, baked products, food supplements and certain foods for a particular nutritional use. EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “helps keep the heart and arteries healthy #C helps maintain healthy blood cholesterol #B helps protect the body tissue and cells from oxidative damage #A” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002655
Black SEA Bass US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002656
Black tea CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002657
Black tea from Camellia sinensis EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Black tea helps you to focus attention” | Non-authorised | Art.13(5) | EFSA opinion |
| “Improves endothelium-dependent vasodilation, which contributes to healthy blood flow” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002658
Black Walnut US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Bee Venoms [CS]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002659
Black Walnut Husk US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002660
Blackberry US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002661
Blackcurrant Ribes nigrum EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Blackcurrant is rich in the antioxidants anthocyanins Blackcurrant is rich in antioxidants” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002662
Blackcurrant seed oil (carbon dioxide extracted) + vitamin E. EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Blackcurrant seed oil increases HDL cholesterol levels. Blackcurrant seed oil reduces LDL cholesterol levels. Blackcurrant seed oil improves the HDL/LDL ratio. Blackcurrant seed oil supports cardiovascular health by regulating fat metabolism and blood pressure.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Blackcurrant seed oil increases HDL cholesterol levels. Blackcurrant seed oil reduces LDL cholesterol levels. Blackcurrant seed oil improves the HDL/LDL ratio. Blackcurrant seed oil supports cardiovascular health by regulating fat metabolism and blood pressure.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Blackcurrant seed oil regulates the immune response. Blackcurrant seed oil maintains and supports the body's normal defence system.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002663
Blainvillea acmella CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002664
blarcamesine hydrochloride EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedN06D
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002665
Blastocystis Hominis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fungal Proteins [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002666
Blatta americana CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002667
Blatta Orientalis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence41 US product listings · 36 Canadian licensed products
Etalyn identifierETA-C-002668
Blattella Germanica US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Allergens [Chemical/Ingredient]; Antigens; Cell-mediated Immunity [PE]
Market presence20 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002669
Blend of Fruit Extracts CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002670
Bleomycin US-DRUG Not yet graded
US: anda
Class as recordedCytoprotective Agent [EPC]
Earliest US approval1973
Market presence15 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002671
Bletilla striata CA-NHP Not yet graded
CA licensed ingredient
Market presence40 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002672
Blue Agave Inulin (agave Tequilana) US-DRUG Not yet graded
US: unapproved drug other
Class as recordedVitamin D [CS]; Vitamin D [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002674
Blue Crab US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002675
Blue green algas CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002676
Blue Skullcap CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002677
Blue Tilapia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002678
Blueberry CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Market presence3 US product listings · 10 Canadian licensed products
Etalyn identifierETA-C-002679
blueberry extracts EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “blueberry can support maintainig of proper night vision” | Non-authorised | Art.13(1) | EFSA opinion |
| “natural antioxidant, protect organism from oxidative damage, natural way to avoid risks caused by oxidation and peroxidation process” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002680
Bluegill US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002681
bluetongue virus EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002682
bluetongue virus serotype 8 antigen EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedQI02AA08
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002683
bluetongue virus vaccine EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI04AA02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002684
bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002685
bluetongue-virus serotype-1 antigen EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedQI04AA02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002686
bluetongue-virus serotype-2 antigen EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI04AA02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002687
bluetongue-virus serotype-4 antigen EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI04AA02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002688
Blumea odorata CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002689
BNT162B2 Omicron (LP.8.1) US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002690
Boehmeria nivea CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002692
Boerhaavia diffusa CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002693
Boerhavia diffusa CA-NHP Not yet graded
CA licensed ingredient
Market presence78 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002694
Boesenbergia rotunda EU-NOVEL Not yet graded
Novel, not yet authorised
also: Boesenbergia baimaii Saensouk & K.Larsen; Boesenbergia cochinchinensis (Gagnep.) Loes.
Parts in scopeRoot
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002695
Bolasterone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-002696
Bolbostemma paniculatum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002697
Boldea fragrans CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002698
Boldenone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesEquipoise; Parenabol; Vebonol; dehydrotestosterone
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-002699
Boldenone Undecylenate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002700
Boldi folium EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Boldo Leaf; Peumus boldus Molina
Class as recordedherbal: Gastrointestinal disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-002701
Boldione US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-002702
Boldo CA-NHP Not yet graded
CA licensed ingredient
Market presence33 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002703
Boletus Satanas Fruiting Body US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002704
Bombax ceiba CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002705
Bombax malabaricum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002706
Bombyx batryticatus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002707
Bombyx mori CA-NHP Not yet graded
CA licensed ingredient
Market presence157 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002708
Bombyx Mori Fiber US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Allogeneic Cultured Cell Scaffold [EPC]; Cell-mediated Immunity [PE]; Collagen [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002709
Bombyx Mori Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Ant Venoms [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002710
Bombyx processionea CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002711
Bone meal CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002712
Bonito Peptide Hydrolysate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002713
Bonito protein peptide EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Natural Blood Pressure Support” “Provides peptides isolated from bonito to support healthy blood pressure levels.” “Provides effective levels of well-researched, specific peptides for healthy blood pressure support.” “Formulated to promote healthy blood pressure levels already within the normal range” “A natural approach for blood pressure support” “Bioactive peptides isolated from bonito fish support blood pressure…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002714
Bonplandia trifoliata CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002715
Borage US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-coagulant [EPC]
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002716
Borage Oil CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings · 5 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “GLA contributes to maintenance of normal skin cell structure and elasticity” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-002717
Borago officinalis CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in foodEU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence1,043 Canadian licensed products
Parts in scopeLeaves, flowers, seeds and seed oil
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Supports the integrity and the fluidity of the cell membrane. Plays an active role in the natural skin rejuvenation. Maintains its suppleness and elasticity/improves cutaneous barrier function in the elderly people/helps maintain transepidermal water balance” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-002718
Borago Officinalis Flower US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Antimalarial [EPC]; Bee Venoms [CS]; Cell-mediated Immunity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002719
Borago Officinalis Seed Oil CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002720
Borassus aethiopum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002721
Borassus flabellifer EU-NOVEL Not yet graded
Not novel in food
also: Borassus flabelliformis L.
Parts in scopeSap
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002722
Borate of sodium CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002723
Borax CA-NHP Not yet graded
CA licensed ingredient
Market presence66 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002724
Borax veneta CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002725
Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedJ07CA09; J07CA12
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002727
Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07CA09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002729